Verily is a precision health technology company with the mission to bring the promise of precision health to everyone, every day.

The company began as a moonshot project at Google X in 2015. Since then, Verily has pushed the boundaries in healthcare by integrating and analyzing diverse data streams that enhance understanding of human health.

Backed by leadership and cross-disciplinary teams with expert clinical, regulatory, and technical knowledge, Verily has built a compliant platform to harmonize disparate health data types, enabling rigorous research, clinical workflows, and innovative care delivery.

The leadership team at Verily is experienced across health, technology, and data science, united by the ambition to make better health possible for all.

Stephen Gillett is the Chairman and CEO, with other key executives including Chief Financial Officer Utpal Koppikar, Chief Technology Officer Scott Burke, and Chief Medical and Scientific Officer Andrew Trister.

Verily's culture emphasizes innovation, velocity as one team, and respect for individuals, aiming to create an inclusive and collaborative environment focused on patient safety, compliance, quality, and building products for diverse populations.

The company is committed to ethical, dependable, and trusted product development and values breaking down silos and acting quickly together.

Verily has multiple offices including its headquarters in Dallas, Texas, and additional hubs in San Francisco, Boston, Raleigh, and Waterloo, supporting growth in engineering, clinical operations, and product management.

Verily strives to innovate healthcare and technology by leveraging AI-driven solutions to improve health outcomes and personalize care, supported by a diverse and passionate team dedicated to transforming healthcare.